Biomarin Pharmaceutical Inc banner

Biomarin Pharmaceutical Inc
XMUN:BM8

Watchlist Manager
Biomarin Pharmaceutical Inc Logo
Biomarin Pharmaceutical Inc
XMUN:BM8
Watchlist
Price: 59.61 EUR -1.86% Market Closed
Market Cap: €11.3B

DCF Value

The DCF Value for Biomarin Pharmaceutical Inc (BM8) under the Base Case is 53 EUR. Compared with the current market price of 59.61 EUR, the stock appears Overvalued by 11% .

Key assumptions
BM8 DCF Value
Base Case
53
Overvaluation 11%
DCF Value
Price €59.61
Explore More DCF Valuations

Reverse DCF

Single-Assumption Reverse DCF
Stress-test one driver at a time

Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett